Align Technology | ALGN - 税前利润



金融业
股票价格
USD
资产
USD 6.42B
现金及等价物
USD 1.1B
销售成本
USD 298.76M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 116.04M
EBIT
USD 191.32M
EBITDA
USD 229.14M
员工
20.95K
EPS每股收益
USD 2.64
股本和储备
USD 4.23B
销售毛利
USD 757.43M
债务利息支出
USD 6.93M
利息收入
USD 3.91M
贷款资金
USD 0
市值
USD 11.04B
净收入
USD 108.29M
营业费用
USD 864.87M
营业利润
USD 191.32M
普通股股本
USD 71.62M
PE价格收益
21.81
税前利润
USD 148.69M
销售收入
USD 1.06B
销售和管理费用
USD 462.67M
股票
USD 212.24M
贸易债权人
USD 109.84M
应收帐款人
USD 1.15B


税前利润 更改 日
3M USD 1.56B 683M 2026-06
Align Technology USD 148.69M 193K 2026-06
Becton, Dickinson and Co. USD 39M 354M 2026-03
Bruker USD 117M 95.1M 2026-06
Cardinal Health USD 782M 390M 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Cooper Companies USD -48.4M 240.6M 2026-03
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
Dexcom USD 269.5M 71.2M 2026-03
Henry Schein USD 137M 13M 2026-06
Idexx Laboratories USD 417.22M 61.78M 2026-06
Insulet USD 118.7M 5.7M 2026-06
Integra LifeSciences USD -2.41M 6.72M 2026-03
IQVIA Holdings USD 301M 5.92B 2026-06
McKesson USD 2.12B 495M 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
Revvity USD 187.24M 137.25M 2026-06
Solventum Corp USD 332M 179M 2025-12
Stryker USD 850M 855M 2026-03
Teleflex USD -3.83M 222.77M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Veeva Systems USD 469.79M 152.26M 2026-03
Waters USD 356M 444M 2026-06
Zimmer Biomet Holdings USD 487.5M 186.2M 2026-06
Zoetis USD 758M 3M 2026-03